Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Fatigue, Gastrointestinal pain, Headache, Impaired gastric emptying, Loss of personal independence in daily activities
Clinical narrative: POTS/ headaches/ nausea/ vomiting/ fatigue/ dizziness/ chronic fatigue/ diarrhea/ chronic diarrhea/ serious and debilitating autoimmune, autonomic, and neurological injuries, including but not limited to POTS/  autonomic and neurological injuries; gastroparesis/ nausea/ vomiting/ gastrointestinal pain/ chronic constipation/ chronic diarrhea/ serious and debilitating autoimmune, autonomic, and neurological injuries, including but not limited to gastroparesis; chronic ovarian cysts/ serious and debilitating autoimmune, autonomic, and neurological injuries, including but not limited to chronic ovarian cyst; serious and debilitating autoimmune, autonomic and neurological injuries/ Serious Autoimmune and Neurological Injuries; seizures; Information has been received from a lawyer regarding a case in litigation concerning a female patient on unknown age (reported as adult at the time of the report). Prior to receiving her of quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (GARDASIL) vaccination, the patient was fun, happy, joyful, healthy person who enjoyed dancing and singing; she was very creative and outgoing. The patient's concurrent conditions, medical history and concomitant therapies were not provided.  On an unknown date (at the age of 15 years old), the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), and then, with the second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (lot #, expiration dates, doses, routes of administration and anatomical locations were not provided for both doses) for preventing cervical cancer, as recommended by her physician, and consented by the patient's mother.  On an unspecified date, (after receiving quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) vaccination), the patient began experiencing gastrointestinal pain, headaches, seizures nausea, vomiting, diarrhea, fatigue and dizziness. She was seen by multiple physicians and specialists for her complaints including cardiologists, neurologists, and gastroenterologist. As a result of her post- quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the patient was unable to engage in activities that a young person her age would normally enjoy. She suffered chronic fatigue and pain which made her difficult to function. Her college performance suffered because of her symptoms, and she was unable to participate in the activities she once did, or to look forward to the future she thought she would have. Based upon her chronic and severe post-quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) symptoms, the patient was diagnosed with various medical conditions, including but not limited to postural orthostatic tachycardia syndrome (POTS), gastroparesis, chronic ovarian cysts, chronic constipation, and chronic diarrhea. She contended, that the quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) injections caused her to develop serious and debilitating autoimmune, autonomic, and neurological, injuries, including but not limited to POTS, gastroparesis, chronic ovarian cysts, chronic constipation, and chronic diarrhea, as well as a constellation of adverse symptoms, complications, injuries, and other adverse events, many of which are alleged herein and all of which were caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) or otherwise linked to her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced autoimmune, autonomic, and neurological disorders. As a proximate result of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), the patient suffered and continued to suffer severe and permanent physical injuries and associated symptomatology and suffered severe and permanent emotional injuries, including pain and suffering. She also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her injuries caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL). As a direct and proximate result of her quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL)-induced injuries, she also suffered and continued to suffer economic losses including considerable financial expenses for medical care and treatment, and diminished income capacity and she would continue to incur these losses and expenses in the future. It was reported, the first time the patient discovered that her injuries could have been caused by quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was in late 2020. The outcome of the events POTS, gastroparesis, ovarian cyst, seizures, autoimmune disorder was not recovered at the time of the report.  The events were considered to be related to quadrivalent human papillomavirus (types 6,11,16,18) recomb vaccine (GARDASIL).  The events of POTS, gastroparesis, ovarian cyst, seizures, and autoimmune disorder were considered to be disabling.  Upon internal review the events of gastroparesis, seizure, and autoimmune disorder were determined to be medically significant.